# Evaluating the Safety, Tolerability, and Pharmacokinetics of BAT1006

> **NCT05414136** · PHASE1 · COMPLETED · sponsor: **Bio-Thera Solutions** · enrollment: 37 (actual)

## Conditions studied

- Advanced Solid Tumor

## Interventions

- **DRUG:** BAT1006

## Key facts

- **NCT ID:** NCT05414136
- **Lead sponsor:** Bio-Thera Solutions
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-02-10
- **Primary completion:** 2024-06-17
- **Final completion:** 2024-06-17
- **Target enrollment:** 37 (ACTUAL)
- **Last updated:** 2024-12-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05414136

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05414136, "Evaluating the Safety, Tolerability, and Pharmacokinetics of BAT1006". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05414136. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*